KZR - Kezar Life Sciences, Inc. -  [ ]

Ticker Details
Kezar Life Sciences, Inc.
IPO Date: June 18, 2018
Sector: Healthcare
Industry: Biotech
Market Cap: $50.02M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.23 | 3.15%
Avg Daily Range (30 D): $0.06 | 0.90%
Avg Daily Range (90 D): $0.06 | 1.04%
Institutional Daily Volume
Avg Daily Volume: .09M
Avg Daily Volume (30 D): .04M
Avg Daily Volume (90 D): .13M
Trade Size
Avg Trade Size (Sh.): 28
Avg Trade Size (Sh.) (30 D): 147
Avg Trade Size (Sh.) (90 D): 136
Institutional Trades
Total Institutional Trades: 544
Avg Institutional Trade: $1.77M
Avg Institutional Trade (30 D): $.69M
Avg Institutional Trade (90 D): $.69M
Avg Institutional Trade Volume: .02M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.61M
Avg Closing Trade (30 D): $4.17M
Avg Closing Trade (90 D): $4.17M
Avg Closing Volume: 23.01K
 
News
Oct 17, 2025 @ 6:38 PM
Kezar Launches Strategic Review As FDA Roadblock D...
Source: Vandana Singh
Oct 5, 2023 @ 3:00 PM
Benzinga's Top Ratings Upgrades, Downgrades For Oc...
Source: Benzinga Insights
Oct 4, 2023 @ 1:32 PM
Kezar (KZR) Falls 10% on Strategic Update, Reduces...
Source: Zacks Equity Research
Sep 21, 2023 @ 11:51 AM
Why Murphy Canyon Acquisition Shares Are Trading H...
Source: Lisa Levin
Sep 21, 2023 @ 10:48 AM
The economy is about to slow down. That's the time...
Source: MarketWatch
Financials
  TTM Q3 2025 Q2 2025
Basic EPS $-8.44 $-1.53
Diluted EPS $-8.44 $-1.53
Revenue $M $M
Gross Profit
Net Income / Loss $-61.71M $-11.23M $-13.7M
Operating Income / Loss $-65.51M $-11.72M
Cost of Revenue
Net Cash Flow $4.08M
PE Ratio    
Splits
Oct 30, 2024 1:10